O'Melveny & Myers Represents Investors in US$40 Series

A Convertible Preferred Stock financing of Alimera Sciences

O’Melveny & Myers LLP represented Palo Alto Investors and Sofinnova Ventures in their co-investment with New Enterprise Associates in the US$40 million Series A Convertible Preferred Stock financing of Alimera Sciences. The closing of the financing is subject to customary closing conditions.

The O’Melveny deal team was led by partners Paul Scrivano and Brian Covotta, counsel Jeff Cislini, and associate Noah Kornblith.

About IPFrontline (7239 Articles)

IPFrontline is a web magazine about intellectual property. The IPFrontline electronic newsletter lands in more than 15,000 e-mail boxes every week, ensuring timely delivery of top news stories and articles appearing in IPFrontline online.

www.ipfrontline.com